Alqahtani_2021_Steroids_172_108857

Reference

Title : Bioactive stigmastadienone from Isodon rugosus as potential anticholinesterase, alpha-glucosidase and COX\/LOX inhibitor: In-vitro and molecular docking studies - Alqahtani_2021_Steroids_172_108857
Author(s) : Alqahtani YS
Ref : Steroids , 172 :108857 , 2021
Abstract :

Natural product is a well-known source of bioactive compounds. Herein, a steroidal compound stigmasta-7,22-diene-3-one (stigmastadienone) has been isolated from Isodon rugosus. The potency of isolated compound has been tested for several in-vitro targets. The acetyl and butyrylcholinesterase assays were performed using Ellman's procedure. For the in-vitro antidiabetic potential, alpha-glucosidase inhibitory assay was performed. Similarly, the cyclo and lipoxygenase pathways were studied to find its potential role in the management of inflammation and analgesia. The 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and hydrogen peroxide (H(2)O(2)) assays were performed for the antioxidant potentials. Docking studies were performed against acetylcholinesterase, cyclooxygenase and lipoxygenase targets. In anticholinesterase assays, stigmastadienone exhibited half-maximal inhibitory concentration (IC(50)) values of 13.52 and 11.53 microg/ml for acetyl and butyrylcholinesterase respectively. The observed IC(50) values for that of galantamine were 6.07 and 4.42 microg/ml for acety and butyrylcholinesterase respectively. In inhibiting alpha-glucosidase enzyme, the compound showed mediocre IC(50) of 109.40 microg/ml compared to the standard acarbose (7.60 microg/ml). The stigmastadienone proved to be an excellent inhibitor of cyclooxygenase 2 (COX-2) and 5-lipoxygenase (5-LOX) attaining IC(50) values of 4.72 and 3.36 microg/ml respectively. The standard drugs IC(50) values for COX-2 (celecoxib) and 5-LOX (montelukast) were 3.81 and 2.74 microg/ml respectively. The enzymatic activities of stigmastadienone were also supplemented with antioxidant results, specifically it was more dominant against DPPH and ABTS free radicals. Docking studies showed that only the carbonyl oxygen is able to form hydrogen bond interaction with the residues. In conclusions, the stigmastadienone has been isolated from Isodon rugosus for the first time. Moreover, the compound has been evaluated for several biochemical pathways which suggest its pharmacological role on the explored targets.

PubMedSearch : Alqahtani_2021_Steroids_172_108857
PubMedID: 33945799

Related information

Citations formats

Alqahtani YS (2021)
Bioactive stigmastadienone from Isodon rugosus as potential anticholinesterase, alpha-glucosidase and COX\/LOX inhibitor: In-vitro and molecular docking studies
Steroids 172 :108857

Alqahtani YS (2021)
Steroids 172 :108857